Today’s top gainers include the company Celgene Corporation (NASDAQ:CELG) which is in the industry Biotechnology, gaining -0.37% today. In the last week its performance is -2.12%, and 13.47% for the past quarter. Currently, Celgene Corporation, CELG has a target price of 136.45, so today’s gain of -0.37% is a significant step towards its target price. The GAP today is therefore -0.56%.
Celgene Corporation (NASDAQ:CELG), has a market cap of 88271.03, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 81.00%.
At the current price of 113.39, it has a dividend yield of *TBA, and its target price is 136.45. This is with a profit margin of 18.90%, and total debt/equity of 0. Celgene Corporation (NASDAQ:CELG) has a P/E of 47.78, as well as a forward P/E of 16.21.
With a current EPS of 2.38, and a forecasted EPS growth for next year at 21.86%,Celgene Corporation (NASDAQ:CELG) has had a EPS growth for the past five years at 15.70%. For the next five years EPS growth is projected to be 21.87%.
Performance for the year is -13.14%. Since its IPO date on 3/26/1990, the total performance to date is -4.97%.
Volume today for Celgene Corporation (NASDAQ:CELG), is 3373916, while its average volume is 4518.01. Whilst the total gain today was -0.37%, it did have a day high of -3.83%.
Volatility for this week has been at 1.83%, and 2.09% for the month. The 52-week low for Celgene Corporation, CELG has been 21.95%, while the 52-week-high has reached -14.49%.
Looking at its return of investments, which is 8.90%, and its return on assets is 7.20%. Celgene Corporation (NASDAQ:CELG) has an operating margin of 27.10%. With a sales growth of 20.90% quarter over quarter. Bearing in mind that Celgene Corporation, CELG is in the sector Healthcare, its long-term debt/equity is 2.58, and has a current ratio of 4.6 and 4.4 for quick ratio.
So what is the value of Celgene Corporation? Well its PEG is 2.18, and the P/S is 8.69, along with a P/B of 15.92. Meanwhile it has a p/cash of 13.78.